Therapeutics: Mammalian target of rapamycin complex 1 (mTORC1); tuberous sclerosis complex tumor suppressor 1 (TSC1)

Mouse studies suggest activating mTORC1 in cones could help prevent blindness in retinitis pigmentosa (RP). In mouse models of both fast-progressing and slow-progressing RP, constitutive activation of...